The substantial elevation of RSPO3 in fibrosis stages F3 and F4 is in an agreement with what we found in CCl4 fibrotic livers, which features the bridging fibrosis pattern that resembles stages 3 fibrosis in human NASH patients. This evidence concerns the gene RSPO3 and metabolic dysfunction-associated steatohepatitis.